Efectos secundarios del tratamiento para la leucemia linfoblástica aguda .. ( PEG-L asparaginasa; Oncaspar®) administrada por inyección. O Vincristina. L-asparaginase, definition: alkylating anticancer drug used in the treatment of L -asparaginasa, definition: fármaco alquilante antineoplásico, utilizado para el Los efectos secundarios más comunes son nauseas, vómitos. y otros efectos adversos de este grupo de fármacos, ya que estos pacientes los efectos citotóxicos de la quimioterapia son mediados por diversos . Actinomicina D, metotrexato, andrógenos, L-asparaginasa, procarbazina, vincristina.

Author: Naramar Vumuro
Country: Comoros
Language: English (Spanish)
Genre: History
Published (Last): 5 July 2013
Pages: 87
PDF File Size: 1.67 Mb
ePub File Size: 12.91 Mb
ISBN: 804-2-23613-820-5
Downloads: 11868
Price: Free* [*Free Regsitration Required]
Uploader: Tor

Son aptos los sujetos que hayan sufrido una alergia previa a la asparaginasa PEG pero que puedan recibir Erwinia. IMP with orphan designation in the indication. For these items you should use the filters and not add them to your search terms in the text field.

Medicinas para Quimioterapia – Nombres de Medicina

Los sujetos deben haber finalizado todo tipo de l-asaraginasa activa p. Age 18 years or younger at the time of study treatment initiation. Active treatment for graft-versus-host disease 6. Combination product that includes a device, but does not involve an Advanced Therapy. Clear advanced search filters.

Subjects are under 18 years old. Plans for treatment or care after the subject has ended the participation in the trial if it is different from the expected normal treatment of that condition.


Both Female Only Male Only. Definition of the end of the trial and justification where it is not the last visit of the last subject undergoing the trial.

Adequate liver function, defined as both of the following: Subjects must have a serum creatinine level that is? Karnofsky or Lansky scores?

EU Clinical Trials Register. Known allergy to Captisol a cyclodextrin derivative used to solubilize carfilzomib; for a complete listing of Captisol-enabled drugs, see the Ligand Pharmaceuticals, Inc.

Title of the trial for lay people, in easily understood, i. Positive culture for bacteria or fungus within 14 days of the initiation of therapy 7. Subjects who have had a previous allergy to PEG-asparaginase but can receive Erwinia are eligible.

Restricciones de tratamientos previos: For agents that have known adverse events occurring beyond 7 days after administration, this period must be extended beyond the time during which adverse events are known to occur.

The duration of this interval must be approved by the Onyx study medical monitor. Clinical trials The European Union Clinical Trials Register allows you to search for protocol and results information on: A group of cancers that usually begins in the bone marrow and results in high numbers of abnormal white blood cells.

How to search [pdf].

Medicinas para Quimioterapia – Nombres de Medicina

Time to toxicity will be evaluated to differentiate single-agent carfilzomib from carfilzomib in combination adevrsos induction chemotherapy? Known allergy to any of the drugs used in the study. Committee on Advanced therapies CAT has issued a classification for this product.


Phase 1b – To assess the safety and tolerability of carfilzomib, alone and in combination with induction chemotherapy, for the treatment of children with relapsed or refractory acute lymphoblastic leukemia ALL -To determine the maximum tolerated dose MTD of carfilzomib in combination with induction chemotherapy.

Cancer AND drug name. Review by the Competent Authority or Ethics Committee in the country concerned. Trials with results Trials without results. Trials with results Trials -lasparaginasa results Clear advanced search filters. The trial involves single site in the Member State concerned. Relapsed or Refractory Acute Lymphoblastic Leukemia.

Clinical trials

Subjects must have fully recovered from the acute toxic effects of all previous chemotherapy, immunotherapy, or radiotherapy treatment before enrollment. Date on which this record was first entered in the EudraCT database:. The IMP has been designated in this indication as an orphan drug in the Community. Pneumonia AND sponsor name.